Consolidated Investment Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.89M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$2.98M |
| 3 |
Marriott International
MAR
|
+$2.77M |
| 4 |
Wabtec
WAB
|
+$2.42M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI China ETF
MCHI
|
+$2.97M |
| 2 |
Emergent Biosolutions
EBS
|
+$1.88M |
| 3 |
Prologis
PLD
|
+$1.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.96% |
| 2 | Financials | 14.33% |
| 3 | Consumer Discretionary | 10.58% |
| 4 | Healthcare | 7.25% |
| 5 | Communication Services | 6.2% |
Similar funds
Consolidated Investment Group's Q4 2020 Portfolio in Review
As of Q4 2020, Consolidated Investment Group held 75 positions worth $383M, up 29% from $297M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Consolidated Investment Group deployed $36.8M of net new capital in Q4 2020, opening 13 new positions and adding to 19 existing holdings. Its largest new stake was UnitedHealth: 11,600 shares worth $4.07M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the most notable exit was iShares MSCI China ETF, an estimated $2.97M sold.
- Consolidated Investment Group's largest Q4 2020 buy was UnitedHealth: 11,600 shares worth $4.07M.
- Consolidated Investment Group added most to Lockheed Martin in Q4 2020, an estimated $1.95M increase.
- Consolidated Investment Group fully exited iShares MSCI China ETF in Q4 2020, selling an estimated $2.97M.
- Consolidated Investment Group's ten largest holdings make up 45% of its $383M portfolio in Q4 2020.
- Consolidated Investment Group opened 13 new positions and closed 3 in Q4 2020.
- Consolidated Investment Group's portfolio value rose 29% quarter-over-quarter to $383M.
Based on Consolidated Investment Group's 13F filing for Q4 2020, filed 19 Jan 2021.